While PAX6 is known to suppress glioma cell proliferation via mechanisms involving the Sonic hedgehog pathway, VEGF signaling, and the sphingosine kinase, its downstream molecular targets and regulatory network remain inadequately defined [14,15,16]. The gene discussed is PAX6; the disease is central nervous system cancer.